Show simple item record

dc.contributor.authorWitchel, Selma Feldman
dc.contributor.authorAzziz, Ricardo
dc.date.accessioned2010-11-17T20:16:06Z
dc.date.available2010-11-17T20:16:06Z
dc.date.issued2010-07-30en_US
dc.identifier.citationInt J Pediatr Endocrinol. 2010 Jun 30; 2010:625105en_US
dc.identifier.issn1687-9856en_US
dc.identifier.pmid20671993en_US
dc.identifier.doi10.1155/2010/625105en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/176
dc.description.abstractNonclassic congenital adrenal hyperplasia (NCAH) due to P450c21 (21-hydroxylase deficiency) is a common autosomal recessive disorder. This disorder is due to mutations in the CYP21A2 gene which is located at chromosome 6p21. The clinical features predominantly reflect androgen excess rather than adrenal insufficiency leading to an ascertainment bias favoring diagnosis in females. Treatment goals include normal linear growth velocity and "on-time" puberty in affected children. For adolescent and adult women, treatment goals include regularization of menses, prevention of progression of hirsutism, and fertility. This paper will review key aspects regarding pathophysiology, diagnosis, and treatment of NCAH.
dc.rightsThe PMC Open Access Subset is a relatively small part of the total collection of articles in PMC. Articles in the PMC Open Access Subset are still protected by copyright, but are made available under a Creative Commons or similar license that generally allows more liberal redistribution and reuse than a traditional copyrighted work. Please refer to the license statement in each article for specific terms of use. The license terms are not identical for all articles in this subset.en_US
dc.titleNonclassic congenital adrenal hyperplasia.en_US
dc.typeJournal Articleen_US
dc.identifier.pmcidPMC2910408en_US
dc.contributor.corporatenameDepartment of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CAen_US
dc.contributor.corporatenameDepartment of Obstetrics and Gynecology, and Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CAen_US
refterms.dateFOA2019-04-09T16:32:49Z
html.description.abstractNonclassic congenital adrenal hyperplasia (NCAH) due to P450c21 (21-hydroxylase deficiency) is a common autosomal recessive disorder. This disorder is due to mutations in the CYP21A2 gene which is located at chromosome 6p21. The clinical features predominantly reflect androgen excess rather than adrenal insufficiency leading to an ascertainment bias favoring diagnosis in females. Treatment goals include normal linear growth velocity and "on-time" puberty in affected children. For adolescent and adult women, treatment goals include regularization of menses, prevention of progression of hirsutism, and fertility. This paper will review key aspects regarding pathophysiology, diagnosis, and treatment of NCAH.


Files in this item

Thumbnail
Name:
IJPE2010-625105.pdf
Size:
559.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record